Lung Therapeutics, Inc. is > 10% Shareholder of TFF Pharmaceuticals, Inc.. Currently has a direct ownership of 2.24 Million shares of TFFP, which is worth approximately $5.59 Million. The most recent transaction as insider was on Mar 26, 2021, when has been sold 715,000 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $10,010,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.24M
0% 3M change
0% 12M change
Total Value Held $5.59 Million

Lung Therapeutics, Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2021
SELL
Open market or private sale
$10,010,000 $14.0 p/Share
715,000 Reduced 24.24%
2,235,000 Common Stock
Dec 04 2020
SELL
Open market or private sale
$14,553,000 $13.86 p/Share
1,050,000 Reduced 26.25%
2,950,000 Common Stock
LTI

Lung Therapeutics, Inc.

> 10% Shareholder
Austin, TX

Track Institutional and Insider Activities on TFFP

Follow TFF Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TFFP shares.

Notify only if

Insider Trading

Get notified when an Tff Pharmaceuticals, Inc. insider buys or sells TFFP shares.

Notify only if

News

Receive news related to TFF Pharmaceuticals, Inc.

Track Activities on TFFP